| PET Scan For »
|
|
|
 |
|
The ECLIPSE systems provide the latest in quality,
design, and engineering. Our smaller cyclotrons make
installation easier while still providing high yields
and unparalleled reliability.
For these reasons, CTI cyclotrons have remained the
standard in radioisotope delivery systems. Designed and
built with the latest technology, ECLIPSE cyclotrons
provide Curie levels of radioisotopes for patient use
every day. |
|
|
|
That’s why ECLIPSE cyclotrons and chemistry modules are used
in more distribution centers than any other system in the
world. With over 100 ECLIPSE cyclotrons installed around the
world, CTI is the industry leader. The CTI ECLIPSE cyclotron
product family, including targetry and chemistry, has a rich
and innovative history extending to the birth of the cyclotron
at the University of California at Berkeley in 1938.
The Cyclotron Company, the RDS 112 was introduced as the first
selfshielding cyclotron. Since then, CTI has continued to push
cyclotron development, being awarded five patents on cyclotron
design in the past seven years.
In 1990, CTI’s RDS 112 became the cyclotron used in the first
radioisotope distribution center. Later, in 1995, CTI
introduced the first cyclotron featuring a deep valley magnet
design, the RDS 111. The evolution of the RDS 111 has produced
the ECLIPSERD, which is the benchmark for research and
development applications.
In 2001, CTI introduced the ECLIPSEHP. The ECLIPSEHP high
current, dual beam configuration allows simultaneous
production on two targets for double the yield, enabling
higher production volumes. With a revolutionary new shield and
targetry design, it builds on the proven design features of
previous models.
CTI has continued to show their dedication to improvement with
the release in 2002 of the ECLIPSEST , the ideal entry level
cyclotron. The ECLIPSEST is fully upgradeable to either the
ECLIPSERD or the ECLIPSEHP. |
|
